Claims for harm from Allergan implants in New York

New York plaintiffs may file in MDL 2921 in the District of New Jersey (Judge Brian R. Martinotti) or pursue claims in New York state court. New York state court has not established a BIOCELL-specific coordinated proceeding, though New York County Supreme Court's Commercial Division and its mass tort practices could accommodate coordinated management. Federal cases originating in New York (S.D.N.Y. or E.D.N.Y.) are transferred to D.N.J. under the MDL consolidation order.

New York's personal injury statute of limitations is three years under CPLR § 214. For latent disease claims, New York applies the discovery rule — the limitations period runs from when the plaintiff discovered or should have discovered the injury. The Court of Appeals has recognized the discovery rule in toxic tort and medical device contexts. For BIA-ALCL, the clock generally begins at diagnosis. New York also has a separate one-year statute of limitations for claims against municipal defendants, which is inapplicable to BIOCELL claims against Allergan.

The primary New York state court venues are New York County Supreme Court (Manhattan, Part 10 for complex tort), Kings County Supreme Court (Brooklyn), and Nassau County Supreme Court (Long Island). The U.S. District Court for the Southern District of New York (Manhattan) before judges such as Denise Cote or Edgardo Ramos handles pre-transfer federal proceedings. New York follows the Frye standard (general acceptance) in state court for novel expert testimony — a meaningful distinction from federal Daubert that affects expert strategy.

New York's BIOCELL exposure is concentrated in New York City (Manhattan plastic surgery corridor on Park Avenue and the Upper East Side), Long Island, Westchester County, and suburban New Jersey border communities whose patients often sought treatment from New York City surgeons. Academic medical centers including NYU Langone, Weill Cornell, and Lenox Hill were among institutions where textured implants were placed during the relevant period. New York's cosmetic surgery market is among the densest per capita in the United States.